You'll never pay taxes on withdrawals of your Roth IRA
You'll never pay taxes on withdrawals of your Roth IRA contributions. And you won't pay taxes on withdrawals of your earnings as long as you take them after you've reached age 59½ and you've met the 5-year-holding-period requirement.
Withdrawals before age 59½
Withdrawals of Roth IRA contributions are always both tax-free and penalty-free. But if you’re under age 59½ and your withdrawal dips into your earnings—in other words, if you withdraw more than you've contributed in total—you could be subject to both taxes and penalties on the earnings portion of the withdrawal.
Withdrawals of your traditional IRA contributions before age 59½ will result in a 10% federal penalty tax plus regular income tax on the entire withdrawal.
See if you qualify for an exception
Withdrawals between ages 59½ & 70½
Restrictions relax at age 59½, and you can withdraw from a Roth or traditional IRA penalty-free for the most part.
In addition, with a Roth IRA, you'll pay no taxes on withdrawals, provided your account has been open for at least 5 years.*
With a traditional IRA, you'll owe taxes on the withdrawals of all earnings and any contributions you originally deducted from your taxes.
But remember: Turning 59½ doesn't mean you have to start withdrawing your money.
Withdrawals at age 70½ & older
If you own a Roth IRA, there's no mandatory withdrawal at any age.
But if you own a traditional IRA, you must take your first required minimum distribution (RMD) by April 1 of the year following the year you reach age 70½. For each subsequent year, you must take your RMD by December 31. The RMD amount is based on your life expectancy and the value of your account.
1
1
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Top 5 Most Recently Viewed Articles
Standex Reports Fiscal First Quarter Results Standex International Corporation (NYSE: SXI) has recently released its financial results for the first quarter of fiscal year 2026, marking a substantial increase in performance compared to the previous year. With sales soaring by 27.6% year-over-year to reach $217.4 million, the company has shown incredible resilience and...
Continue Reading
Nasdaq 100 Approaching Historic Peaks Recently, the Nasdaq 100 futures have shown notable resilience, climbing more than 3% as they responded positively to key support levels established the prior week. Currently, the index is flirting with new all-time highs, merely 300 points away from breaking past significant barriers that could reshape market expectations. Key...
Continue Reading
Investigation Announced for Jayud Global Logistics Investors Attention shareholders of Jayud Global Logistics Limited (NASDAQ: JYD). Recent developments surrounding this company have led to significant concerns about the accuracy of their public statements. An investigation is currently being initiated for investors who may have incurred losses. The Nature of the...
Continue Reading
Adona Medical's First-in-Human Study on Innovative Shunt Adona Medical, a company well-known for its cutting-edge solutions for heart failure management, recently made significant strides with its new interatrial shunt technology. The company is spearheading its first-in-human study to assess the capabilities of this innovative device, which aims to enhance the...
Continue Reading
Hyundai Motor's Q3 Profit Decline: Key Insights Hyundai Motor Co, a leading name in the automotive sector, has announced a noteworthy decline in its third-quarter operating profit. This shift marks a 7% decrease compared to the previous year's performance, signaling the impact of a global slowdown in car demand on the company. Understanding the Financial Figures For the...
Continue Reading